Home - Clinical Trials Arena
WEBAt the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be allowed to advance without political interference. Catherine Longworth. Analyst Comment.
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Biosimilars: top 10 pharma companies leading the way
WEBJan 20, 2022 · Yesterday (19 January), using the same Thematic Research ecosystem, Clinical Trials Arena revealed the top pharma companies best equipped with artificial intelligence. According to our analysis, Novartis, Pfizer, Catalent, Amgen, Biogen, Patheon, Shanghai Henlius Biotech, Viatris, Celltrion, and Samsung Bioepis are …
Tesofensine Anti-Obesity Medication - Clinical Trials Arena
WEBDec 14, 2008 · Dose-dependent adverse gastrointestinal effects were observed with tesofensine in the clinical trials in addition to increases in blood pressure and heart. However, at the anticipated therapeutic dose of 0.5mg, discontinuations for adverse effects with tesofensine were similar to placebo (8%). In …
pharmaceutical SMEs take the innovative edge - Clinical Trials Arena
WEBApr 18, 2012 · Small players, big drugs – pharmaceutical SMEs take the innovative edge. Medical advances are leading to more novel therapeutics but it's small biotech, not Big Pharma, which stands to gain the most. Elly Earls meets the brains behind some of the most innovative medicines currently breaking into the market to …
Regulatory Roundup: CytoDyn's Cancer Asset Leronlimab Set to …
WEBDec 6, 2021 · Leronlimab solid tumour trial completed. CytoDyn’s leronlimab for CCR5+ locally advanced or metastatic solid tumours saw its PTSR increase in multiple cancer indications after its Phase II basket trial completed.The trial looked at 22 cancer types, and the largest PTSR changes occurred in glioblastoma multiforme (GBM), throat cancer, and bladder cancer.
Exscientia to start world-first trials of AI-designed immuno …
WEBApr 9, 2021 · A joint venture between Exscientia and Evotec has led to the co-invention and development of an A2a receptor antagonist for adult patients with advanced solid tumours, applying Exscientia’s next-generation AI-powered drug discovery platform, Centaur Chemist. The drug is the first AI-designed molecule for immuno-oncology to enter human ...
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
Cilansetron - New Treatment for IBS - Clinical Trials Arena
WEBNov 28, 2004 · Overall, results from these trials showed that cilansetron is significantly more effective than placebo in male and female patients with diarrhoea-predominant IBS, an important finding given the traditionally high placebo response rates seen in clinical trials of IBS drugs. Overall responder rates (adequate relief in at least 50% of weekly ...
GSK’s Shingrix shows to offer ten years of shingles protection in …
WEBOct 20, 2022 · GSK has reported positive interim data from the ZOSTER-049 extension study, where its recombinant, adjuvanted Zoster vaccine, Shingrix, showed to offer a minimum of ten years of protection against shingles (herpes zoster) following preliminary vaccination.. ZOSTER-049 is an open-label, long-term follow-up study from two Phase III randomised clinical trials, ZOE-50 and ZOE-70.